ABVX vs. SPRY, ETNB, IMNM, EOLS, OPK, ZNTL, TNGX, AUPH, LBPH, and ARCT
Should you be buying ABIVAX Société Anonyme stock or one of its competitors? The main competitors of ABIVAX Société Anonyme include ARS Pharmaceuticals (SPRY), 89bio (ETNB), Immunome (IMNM), Evolus (EOLS), OPKO Health (OPK), Zentalis Pharmaceuticals (ZNTL), Tango Therapeutics (TNGX), Aurinia Pharmaceuticals (AUPH), Longboard Pharmaceuticals (LBPH), and Arcturus Therapeutics (ARCT). These companies are all part of the "pharmaceutical preparations" industry.
ARS Pharmaceuticals (NASDAQ:SPRY) and ABIVAX Société Anonyme (NASDAQ:ABVX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.
ARS Pharmaceuticals' return on equity of 0.00% beat ABIVAX Société Anonyme's return on equity.
ARS Pharmaceuticals currently has a consensus target price of $18.50, suggesting a potential upside of 104.65%. ABIVAX Société Anonyme has a consensus target price of $34.20, suggesting a potential upside of 146.93%. Given ARS Pharmaceuticals' higher possible upside, analysts clearly believe ABIVAX Société Anonyme is more favorable than ARS Pharmaceuticals.
ARS Pharmaceuticals received 5 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users.
68.2% of ARS Pharmaceuticals shares are held by institutional investors. Comparatively, 47.9% of ABIVAX Société Anonyme shares are held by institutional investors. 40.1% of ARS Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
ABIVAX Société Anonyme has lower revenue, but higher earnings than ARS Pharmaceuticals.
In the previous week, ABIVAX Société Anonyme had 1 more articles in the media than ARS Pharmaceuticals. MarketBeat recorded 4 mentions for ABIVAX Société Anonyme and 3 mentions for ARS Pharmaceuticals. ABIVAX Société Anonyme's average media sentiment score of 1.87 beat ARS Pharmaceuticals' score of 1.28 indicating that ARS Pharmaceuticals is being referred to more favorably in the media.
Summary
ARS Pharmaceuticals beats ABIVAX Société Anonyme on 6 of the 11 factors compared between the two stocks.
Get ABIVAX Société Anonyme News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ABIVAX Société Anonyme Competitors List
Related Companies and Tools
